GOED: The biggest opportunity is to educate healthcare providers in primary care

By Stephen Daniells contact

- Last updated on GMT

A new education program by GOED will seek to target primary care practitioners, with the focus on educating the people most likely to influence consumer purchases of the omega-3s.

Speaking with NutraIngredients-USA at the recent SupplySide West show in Las Vegas, Adam Ismail, executive director of the Global Organization for EPA and DHA Omega-3s (GOED), explained the association’s development of this new education campaign.

“A few years ago we had the omega-3 coalition campaign when a bunch of companies came together to fund an advertising campaign in the US with the goal to reverse the decline in consumption of omega-3 supplements,” ​explained Ismail. “It was successful but we couldn’t get funding to continue. It’s expensive to run a national  advertising campaign, so a small group of companies said they were still interested in funding long-term objectives and trying to grow consumption of omega-3s so is there another way of doing that?

“We said we should target the influencers of consumers. We know from the consumer work we do that in almost every country in the world doctors are the most influential source of omega-3 purchases on a consumer. So we started looking at what can do to educate doctors and the first thing we need to do is to study the baseline: What are doctors’ attitudes and awareness of omega-3 benefits?

“What we’ve identified is the biggest opportunity is to educate providers in the primary care environment, so that includes family practitioners, GPs, nurse practitioners, physician assistants, pharmacists. We’re in the research stages now but the goal is to develop an education campaign around that.”

Where are we with the qualified health claim for blood pressure?

NutraIngredients-USA also asked about progress with the association’s blood pressure-related qualified health claim petition.

“The FDA just recently asked for another extension,” ​said Ismail. “There have been other qualified health claim petitions that have gone through that were submitted after ours and approved faster than ours. When we talked to the FDA, part of it is that our petition is a lot more complex than the other ones because there are so many more studies to go through. We have a meta-analysis that we funded to support the claim, but FDA actually looks at each individual studies that go into the meta-analysis and it was a big meta-analysis.

“It’s a big task for FDA, and we’re still optimistic.”

GOED Exchange 2018

These topics and more will be discussed at the upcoming GOED Exchange​, February 6-8, 2018 in Seattle. For more information and to register, please click HERE​.

Related products

show more

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals | 09-Oct-2017 | Technical / White Paper

A Brand Owner/Own Label Distributor is 100% responsible for the quality of their products - not the Contract Manufacturing Organization. This is exactly...

Resveratrol – Revitalizing Cognitive Function

Resveratrol – Revitalizing Cognitive Function

Evolva | 29-Sep-2017 | Technical / White Paper

Cognitive decline is fast becoming the biggest concern of the 65+ population. A population which is set to reach 1.1 billion by 2030*.  · 80% of 60+ take...

Transparency and Dietary Supplement Quality

Transparency and Dietary Supplement Quality

Gemini Pharmaceuticals | 18-Sep-2017 | Technical / White Paper

A Brand Owner is 100% responsible for the quality of their products - not the Contract Manufacturing Organization (CMO). This is exactly why Gemini Pharmaceuticals developed...

KERANAT, the hair loss solution.

KERANAT, the hair loss solution.

Robertet Health & Beauty | 14-Sep-2017 | Technical / White Paper

KERANAT's development is based on an innovative mechanism of action. KERANAT acts directly on the dermal papilla, the biological engine of hair, in...

Related suppliers

Follow us


View more